Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hospice × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Breast Neoplasms 2358 Carcinoma, Non-Small-Cell Lung 1906 Prostatic Neoplasms 1234 Colorectal Neoplasms 1095 Neoplasms 1051 Multiple Myeloma 913 Lung Neoplasms 881 Neoplasm Metastasis 854 Leukemia, Myeloid, Acute 827 Lymphoma 757 Melanoma 744 Pancreatic Neoplasms 700 Ovarian Neoplasms 682 Carcinoma, Hepatocellular 652 Recurrence 648 Stomach Neoplasms 645 Leukemia 636 Lymphoma, Non-Hodgkin 575 Leukemia, Lymphocytic, Chronic, B-Cell 557 Lymphoma, Large B-Cell, Diffuse 528 Squamous Cell Carcinoma of Head and Neck 527 Precursor Cell Lymphoblastic Leukemia-Lymphoma 510 Head and Neck Neoplasms 509 Brain Neoplasms 505 Glioblastoma 497 Carcinoma, Renal Cell 491 Rectal Neoplasms 485 Myelodysplastic Syndromes 445 Sarcoma 438 Lymphoma, Follicular 435

Interventions

Psychotherapy 1 Psilocybin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡